Composition
- Active ingredients
- DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML · For suspensionThis page
- DICLOXACILLIN SODIUM EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA050011-003 · Discontinued
- DICLOXACILLIN SODIUM EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA050011-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050092.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Pathocil
- Active substance
- dicloxacillin sodium
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Wyeth Ayerst
- Status
- Discontinued
- FDA approval
- 22 Apr 1968
- Application
- NDA050092-001